Tracker › Companies › Tela Bio, Inc.
3 No sign of it. We found no public evidence tying Tela Bio, Inc.'s cuts to AI.
Every tracked 2026 layoff at Tela Bio, Inc., newest first. Scores are 0–100: how strongly the public evidence ties the cuts to AI. Sources are linked on each one.
AI score 3/100 (Minimal) · 80% interval 2–4 · evidence grade D · US · Instruments / Medical Devices
Stated reason: On August 28, 2026, the Board of Directors (the “ Board ”) of TELA Bio, Inc. (the “ Company ”) approved a reduction in workforce (the “ Plan ”) in order to reduce the Company’s operating expenses and preserve capital to focus on improving product sales to support increasing future revenue growth. The Plan will reduce the Company’s workforce by approximately 20%, from 201 full-time employees to 160 full-time employees…
Why 3: Plant, store or site closure · Drivers: contrary evidence −0.7, industry AI exposure +0.5
Evidence: SEC filing. Signals: attribution 0.0, primary source 0.0, exec statement 0.0, role exposure 0.828, industry exposure 0.712, AI investment 0.0, contrary evidence 0.4 · named roles: Computer and Information Systems Managers, General and Operations Managers, Sales Representatives, Wholesale and Manufacturing, Except Technical and Scientific
Headcount basis: not disclosed
Scores are evidence-based estimates from a published model, not findings that AI caused any layoff. Spot something wrong or missing? Tell us.
Other Health Care & Pharma layoffs we track.
Health Care & Pharma · 3,800 workers
Health Care & Pharma · 648 workers
Health Care & Pharma · 419 workers
Health Care & Pharma · 365 workers
Health Care & Pharma · 300 workers
Health Care & Pharma · 120 workers
